Notably, in the list, the so-called disruptors of the insurance industry are the ones whose CEOs appear to be winning financially even though their stock performance has left much to be desired.
Payers are increasingly leveraging collaborative partnerships to develop AI models designed to improve early intervention for high risk patients. Health insurers are also interested in collaborating with providers to expand virtual care to not only provide more flexibility to members, but to also provide more effective platforms for triaging patients when they need care.
As part of itsEnvision U.S. Healthcare Summit, Microsoft conducted interviews with executives at Aetna CVS Health and Humana to highlight some of the ways these companies are adapting to consumerization of healthcare.
We personally invite you to join us at Pegasus Park in Dallas on Wednesday, September 28 to partake in thought provoking panel discussions. Plus, this event offers an 6:1 ratio of attendees to investors for those seeking funding and a desire to network.
Don't miss this valuable opportunity to save $100 with our Early Bird Rate (ends 8/26).
By Frank Vinluan Tuesday, August 23, 2022 12:01 PM
The Aerie Pharma acquisition brings Alcon two commercialized glaucoma products, as well as a pipeline of programs in various stages of development for other eye diseases. Alcon has been an active dealmaker, turning to M&A as a way to bolster its eye products portfolio and pipeline.
Today, the pharmaceutical industry is undergoing a rapid and dynamic transformation. Successful contract management plays an instrumental role in navigating this landscape.
No comments